ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,466.06
      -1.61%
      US Tech 100
      18,718.80
      -2.63%
      Dow Jones
      40,007.95
      -0.87%
      Brent Oil
      81.405
      0.78%
      Bitcoin
      66,455.24
      0.81%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Europe
      5. EU

      6. GeNeuro SA (GNRO) Quote

      GeNeuro SA

      GeNeuro SA (GNRO)

      EU
      0.0696
      0.00
      ( 0.00% )
      Updated: 11:09:37
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      0.0696
      Bid
      0.0604
      Ask
      0.0698
      Volume
      72,750
      0.0558 Day's Range 0.07
      0.0558 52 Week Range 2.35
      Market Cap
      2.071M
      Previous Close
      0.0696
      Open
      0.0696
      Last Trade
      2200
      @
      0.0696
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      104,581
      Shares Outstanding
      29,760,933
      Dividend Yield
      -
      PE Ratio
      -
      Earnings Per Share (EPS)
      -
      Revenue
      -
      Net Profit
      -

      About GeNeuro SA

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.geneuro.com
      Headquarters
      Geneva, Che
      Founded
      1970
      GeNeuro SA is listed in the Pharmaceutical Preparations sector of the Euronext with ticker GNRO. The last closing price for GeNeuro was 0.07 €. Over the last year, GeNeuro shares have traded in a share price range of 0.0558 € to 2.35 €.

      GeNeuro currently has 29,760,933 shares outstanding. The market capitalization of GeNeuro is 2.07 € million.

      GNRO Latest News

      More News

      GeNeuro Announces That It Submits a Request for a Debt Moratorium to the Geneva Court of First Instance

      Regulatory News: GeNeuro (Euronext Paris : CH0308403085 - GNRO), a biopharmaceutical company developing new treatments for neurodegenerative and autoimmune diseases such as multiple sclerosis...

      July 15 2024
      Business Wire

      GeNeuro : Fin du contrat de liquidité conclu avec GILBERT DUPONT

      Regulatory News: La société GENEURO (Paris:GNRO) et la société GILBERT DUPONT ont mis fin au contrat de liquidité conclu le 06 mars 2021. Cette résiliation a pris effet le 30 juin 2024 au soir. A...

      July 10 2024
      Business Wire

      Geneuro SA: Half-Yearly Report on the Liquidity Contract with Gilbert Dupont

      Market: Euronext Paris ISIN code / Mnemo: CH0308403085 / GNRO Web site: www.geneuro.com Regulatory News: Pursuant to the liquidity contract entrusted by GENEURO SA (Paris:GNRO) to Gilbert Dupont...

      July 03 2024
      Business Wire

      GeNeuro annonce les résultats de l’essai GNC-501 dans le syndrome post-Covid-19

      Regulatory News: GeNeuro (Euronext Paris: CH0308403085 – GNRO): L'essai clinique GNC-501 est une étude de phase 2 chez des patients souffrant de syndromes neuropsychiatriques post-COVID-19...

      June 28 2024
      Business Wire

      GeNeuro Announces Approval of all Resolutions Proposed at 2024 Annual General Meeting

      81.54% of the Company’s share capital was represented at the AGM and resolutions were all unanimously approved Regulatory News: GeNeuro (Euronext Paris: CH0308403085 - GNRO), a biopharmaceutical...

      June 14 2024
      Business Wire

      Availability of documents and information for the annual shareholders’ meeting of June 12, 2024

      Regulatory News: GeNeuro (Euronext Paris : CH0308403085 - GNRO), a biopharmaceutical company focused on halting the progression of neurodegenerative and autoimmune diseases such as multiple...

      May 29 2024
      Business Wire

      GeNeuro annonce la dernière visite du dernier patient dans son étude post-COVID et confirme que les principaux résultats seront disponibles à fin juin 2024

      L'étude GNC-501 contre le post-Covid a réalisé la dernière visite de patient permettant de finaliser l’étude. L'objectif de l'étude est d'évaluer l'efficacité et l'innocuité du temelimab sur...

      May 16 2024
      Business Wire

      GeNeuro Publishes its 2024 Universal Registration Document

      Regulatory News: GeNeuro (Euronext Paris: CH0308403085 – GNRO), a biopharmaceutical company developing novel treatments for neurodegenerative and autoimmune diseases such as multiple sclerosis...

      May 02 2024
      Business Wire
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.0218-23.85120350110.09140.09880.0558689190.07973723DE
      4-1.8104-96.29787234041.881.880.05582639050.15475708DE
      12-1.3754-95.18339100351.4452.350.05581045810.3324627DE
      26-1.1304-94.21.22.350.0558532770.3908643DE
      52-1.5104-95.59493670891.582.350.0558304010.50679235DE
      156-3.4804-98.03943661973.554.390.0558134761.08124811DE
      260-2.9304-97.6836.280.0558105981.73028314DE

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      NUZENuZee Inc
      $ 2.86
      (177.67%)
      		77.76M
      DRMADermata Therapeutics Inc
      $ 2.79
      (114.62%)
      		53.5M
      SLNASelina Hospitality PLC
      $ 0.0545
      (109.62%)
      		713.42M
      PIRSPieris Pharmaceuticals Inc
      $ 14.75
      (84.84%)
      		4.33M
      QXOQXO Inc
      $ 130.00
      (63.93%)
      		82.62k
      NXTTNext Technology Holding Inc
      $ 1.88
      (-67.70%)
      		448.32k
      ATPCAgape ATP Corporation
      $ 0.1363
      (-36.60%)
      		4.55M
      NUWENewellis Inc
      $ 2.64
      (-36.39%)
      		783.32k
      CONNConns Inc
      $ 0.338
      (-33.33%)
      		2.47M
      VWEVintage Wine Estates Inc
      $ 0.078
      (-30.29%)
      		18.35M
      SLNASelina Hospitality PLC
      $ 0.0546
      (110.00%)
      		713.44M
      SGMOSangamo Therapeutics Inc
      $ 0.5362
      (33.62%)
      		171.29M
      NVDANVIDIA Corporation
      $ 117.785
      (-3.92%)
      		85.51M
      TSLATesla Inc
      $ 217.6821
      (-11.65%)
      		81M
      NUZENuZee Inc
      $ 2.86
      (177.67%)
      		77.76M

      Discussion

      View Full Feed
      familyof5 familyof5 2 minutes ago
      "There is no day after if they don't get approval"

      It's trading the way it is because there is no more momentum play left. All the catalyst events have happened. If you invest today, it's all or nothing. There is no day after if they don't get approval. The company has been really qui
      RDGL
      peanutz peanutz 2 minutes ago
      I don't pump . Watch level 2 . Jumping a whole penny at times . Wild ride
      SLNA
      Edward Edward 2 minutes ago
      princess just hates Jim.

      Can't stop laughing.

      Doesn't even know CEO Jim or cares about the CEO or VXIT stock.
      VXIT
      MDA MDA 2 minutes ago
      Does anyone go to these anymore???

      I didn't go to the one in Manhattan in 2021 when I was making money on this ticker.
      DPLS
      gail gail 2 minutes ago
      i should have waited longer, lol.
      BBLG
      arachnodude arachnodude 2 minutes ago
      Exactly!
      KBLB
      XenaLives XenaLives 2 minutes ago
      Plaque attack drugs will not work long term because plaque is a symptom, not a cause.

      Fromm your link:

      "About Buntanetap

      Buntanetap (formerly known as Posiphen or ANVS401) targets neurodegeneration by inhibiting the formation of multiple neurotoxic protei
      AVXL
      Louie_Louie Louie_Louie 2 minutes ago
      Agree. KThomp advocating for a very stremlined exit scenario and trying to pass tha of as a given, Da Jester pointed this out numerous times. There's no just one solution. Ffffunk'n Ffffacts living in the past, dancing and praising MC, who lied about stress tests and was spineless against Waters
      52172 52172 2 minutes ago
      Not true
      AQST
      delerious1 delerious1 3 minutes ago
      Live: Protesters gather in Washington for Netanyahu address to Congress

      [yt]sS85K30Gsp0[/yt]
      Risk Risk 3 minutes ago
      Any better priced ones in pennies or sub-pennies you are looking into? Just to divert my attention from here :))
      AFFU
      Nemesis18 Nemesis18 3 minutes ago
      I'd suggest that you cash out totally from this stock , as it's DOOOOMMED,.
      Doomed I tell you !!! 😳🥴☝️
      NWBO
      PEACHMAN PEACHMAN 3 minutes ago
      Is it time to accumulate LDSN again?
      LDSN
      BoscoLives21 BoscoLives21 3 minutes ago
      Your tactics make it obvious who’s on the payroll here. I post because I’m invested and tired of hedgie manipulation. I’ve answered your request for a screen shot repeatedly, maybe read my responses.
      Great company, making steady progress, do your own DD and ignore the noise!
      $KEGS
      KEGS
      LVerstee LVerstee 3 minutes ago
      Thank you. If indeed Paladin turns up dead then your message will be one that requires answers.
      ITUP
      Carjockey2 Carjockey2 3 minutes ago
      Nahhh..lol

      You waiting for .002

      LMAO
      HIRU
      $Green$ $Green$ 3 minutes ago
      No patience. With such lofty valuations, why try to catch a falling knife so quickly?
      SPY
      zab zab 3 minutes ago
      At least you know how stupid you are.
      Wise Man Wise Man 4 minutes ago
      Dude, FnF post $0 EPS every quarter, due to the ongoing Common Equity Sweep (NWS 2.0), brought to you by the Trump Administration.
      if there are rumors of a good quarter it rises slightly before earnings release and/or pops if rumors are true .
      READ
      https://investorshub.advfn.
      FNMA
      zab zab 4 minutes ago
      John Malone, Republican controlled media.
      DKLN DKLN 4 minutes ago
      If the rule is to buy low and sell high, why aren't the people who have been saying wonderful things about this "company"/stock for years not buying? If they don't don't believe in this "company"/stock enough to buy, than most everyone else, who have doubts, aren't buying either. It's as simple as t
      MCIC
      Demolition Man Demolition Man 4 minutes ago
      Hmmm, I’m not trying to argue. I’m talking about certain things like the big town hall where hundreds of locals could do a Q &A in person with Mark and team like they did over 7+ years ago. I just want to focus on the last big TV interview, news podcast or any podcast, local or national radio progra
      NB
      delerious1 delerious1 5 minutes ago
      Live: Protesters gather in Washington for Netanyahu address to Congress

      [yt]sS85K30Gsp0[/yt]
      Huggy Bear Huggy Bear 5 minutes ago
      Man, it's a who's who of con artists around here.
      IFUS

      Your Recent History

      EU
      GNRO
      GeNeuro
      USOTC
      BGES
      Bio Bridge Science (CE)
      LSE
      VRS
      Versarien
      Delayed Upgrade Clock